Predictive analytics is an area of data science that is getting a lot of attention in health care.
Predictive analytics offers a tantalizing solution to problems plaguing resource-restrained hospitals. Namely, if providers can predict which patients will be readmitted within 30 days, or who will acquire an infection in the hospital, they can apply scarce resources to those high-risk patients and change the predicted outcome. This has the potential to improve quality outcomes and lower costs. Continue reading
For three years, the Centers for Medicare & Medicaid Services (CMS) have penalized hospitals when the institutions show unacceptably high rates of potentially avoidable complications, such as blood clots, bed sores, and infections, Jordan Rau reported last month for Kaiser Health News.
The federal agency this year added penalties for two hospital-acquired infections that result from germs resistant to antibiotics: methicillin-resistant Staphylococcus aureus (known as MRSA) and Clostridium difficile (C. diff). Continue reading
Nursing home star ratings are misleading and disingenuous, according to a recent analysis comparing ratings with quality measures alone. More than a thousand nursing homes nationally with high overall ratings had only one or two stars in quality measures, which could point to some serious health implications for residents. Continue reading
Photo courtesy of The Dark ReportInvestigative reporter Ellen Gabler addressed a New Orleans meeting of clinical laboratory professionals at the annual Lab Quality Confab.
Last fall, I was fortunate to hear journalist Ellen Gabler give a presentation about one of her investigations to a gathering of administrators, executives and pathologists in the clinical laboratory industry.
The session at Lab Quality Confab in New Orleans was unusual because journalists rarely are invited to talk about their work before the industry they cover. Continue reading
Perhaps you stumble onto an intriguing study that you haven’t seen covered and want to report on it. Or you receive a press release touting provocative findings that sound pretty astonishing … if they’re true. One potential indication of the paper’s significance and quality is the journal in which it was published.
Publication in a highly regarded journal is not a guarantee in itself that the paper is good – the blog Retraction Watch has hundreds of examples of that. In fact, one of the most famously retracted studies of all time – that of Andrew Wakefield’s attempt to link autism and vaccines in a small cases series – was published in The Lancet, one of the top medical journals in the U.K. (Ironically, that study continues to contribute to The Lancet’s impact factor because it’s the second-most-cited retracted paper as ranked by Retraction Watch.) Continue reading